The AR and the TMPRSS2-ERG fusion product (present in over 50% of localized PCa and whose expression is controlled by the AR) are known to coordinately regulate GNMT and SARDH expression [20,21]. The gene discussed is GNMT; the disease is posterior cortical atrophy.